Sharma said the team-based model should flag patients with multiple cardiovascular risk factors—hypertension, diabetes, high cholesterol, obesity, arrhythmias, or established disease such as heart ...

Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone ...

Anxiety, brain fog, and mood changes in midlife patients warranted validation and a structured evaluation that considered ...

Fezolinetant was linked to early improvements in bothersome hot flushes and night sweats. Real-world data showed better ...

Wen Shen, MD, highlights perimenopause as an important period for identifying health risks and supporting healthy aging ...

Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address ...

A review finds post-miscarriage ultrasound heterogeneity is common and that symptoms, not endometrial thickness, should guide management after EPL.

In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about ...

Soma Mandal, MD, Medical Director, Women's Health, Hackensack Meridian Jersey Shore University Medical Center and Farmingdale, NJ location. Soma Mandal, MD, is launching “Mind, Body, & the Pause: the ...

Objective sleep data captured by actigraphy in the phase 4 OPTION-VMS study corroborated patient-reported sleep improvements with fezolinetant (Veozah), according to Marla Shapiro ...

In recognition of PMOS Awareness Month, Contemporary OB/GYN, Contemporary Pediatrics, and Patient Care Online released a ...

Anita Nelson, MD, discusses the FDA's approval extending etonogestrel implant use to 5 years and the new REMS certification ...